Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
flu, RSV and COVID-19
Respiratory virus season is back. Here's how to protect against flu, COVID-19 and RSV
Flu, COVID-19 and RSV are predicted to cause about as many hospitalizations as last year. Houston experts offer tips for protecting against respiratory viruses.
Yes, you can get the COVID, flu, and RSV vaccines at once. Here are the pros and cons
You may have been too young to remember, but depending on your state’s school immunization requirements, you likely received a slew of vaccines before you started day care, preschool, or kindergarten.
COVID-19, the flu and colds are back: Here’s your seasonal illness guide to respiratory viruses and their symptoms
Back-to-school season also means a return to all those seasonal illnesses we know and don’t love. So how bad will respiratory viruses get this fall? Here’s your guide on what to expect when it comes to flu,
How to tell if you have Covid, flu, RSV or a cold - symptoms to look out for
The NHS has warned there could be a 'tripledemic' this year as people fall ill with Covid, flu and RSV. But there are ways you can figure out what virus you have picked up
2d
RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...
16h
What you need to know about the new RSV vaccine
As the days grow cooler, families across Utah are reminded that respiratory viruses, particularly Respiratory Syncytial Virus ...
1d
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
McKnight's Long-Term Care News
1d
RSV vaccine still 43.3 percent effective 3 years after people take it, trial shows
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...
2d
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
1d
GSK RSV shot 43% effective against severe disease in third year
GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...
FierceBiotech
1d
'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout
In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...
The American Journal of Managed Care
9h
Identifying Post-Discharge Care Needs Among Adults Hospitalized with RSV
Study compares immediate post-discharge care requirements for respiratory syncytial virus (RSV), influenza, acute myocardial ...
ABC News
13d
Researchers investigate potential link between RSV and sudden unexpected infant deaths
Rates of SUID per 100,000 live births rose by 10% from 2019 to 2021. A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of respiratory syncytial virus ...
1d
Topic: RSV
The vaccine is recommended for use only in the run-up to RSV season. It's time for RSV, flu, and COVID shots, and the CDC has ...
extra
19h
Kathryn Thomas reflects on daughter’s ‘terrifying’ RSV diagnosis at just three weeks old
Kathryn Thomas has reflected on rushing her daughter to the hospital after she contracted RSV at just three weeks old.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
COVID
Pfizer
GSK
United States
Arexvy
Feedback